Pharmacologic interventions targeting HDL to reduce atherosclerosis have been less successful than those targeting the apoB side of the equation.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.